Canada markets close in 1 hour 43 minutes

Baxter International Inc. (BAX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
87.97+0.90 (+1.03%)
As of 2:17PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close87.07
Open87.74
Bid87.87 x 800
Ask87.88 x 900
Day's Range87.38 - 88.11
52 Week Range74.79 - 94.01
Volume711,765
Avg. Volume2,711,683
Market Cap44.493B
Beta (5Y Monthly)0.68
PE Ratio (TTM)41.30
EPS (TTM)2.13
Earnings DateApr. 29, 2021
Forward Dividend & Yield0.98 (1.13%)
Ex-Dividend DateFeb. 25, 2021
1y Target Est92.06
  • Business Wire

    Baxter Recognized Globally for Inclusion Efforts

    Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been recognized by the Global Inclusion Index in 11 countries for its inclusion efforts. Baxter Brazil, China, France, Germany, India, Ireland, Italy, Japan, Mexico, Singapore and the UK earned spots on the inaugural Index. The recognition is presented by Seramount (formerly Working Mother Media), the company that produces the U.S.-based Inclusion Index of which Baxter has also been named. The new Global Inclusion Index assesses corporate efforts at hiring and promoting women, with the ability to measure other underrepresented groups on a country-specific basis; creating inclusive cultures; and holding country leaders and managers accountable for results. Baxter was recognized in all countries for which it applied.

  • Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research
    Business Wire

    Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research

    Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced it received a new research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF). With the grant, Baxter will lead an initiative aiming to create a new technology platform enhancing the ability to target selective removal of pathogenic substances during certain extracorporeal (outside the body) blood purification (EBP) therapies. The grant provides €1.5 million in funding over three years to Baxter and its research partners through the BMBF’s "Biomaterials Platform: Mat2MedTech" program.

  • How Many Baxter International Inc. (NYSE:BAX) Shares Do Institutions Own?
    Simply Wall St.

    How Many Baxter International Inc. (NYSE:BAX) Shares Do Institutions Own?

    The big shareholder groups in Baxter International Inc. ( NYSE:BAX ) have power over the company. Insiders often own a...